Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Prestige Consumer Healthcare (PBH) over the last 15 years, with Q4 2025 value amounting to $272000.0.

  • Prestige Consumer Healthcare's Exchange Rate Effect rose 11310.21% to $272000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 million, marking a year-over-year increase of 19349.66%. This contributed to the annual value of -$573000.0 for FY2025, which is 41833.33% down from last year.
  • Prestige Consumer Healthcare's Exchange Rate Effect amounted to $272000.0 in Q4 2025, which was up 11310.21% from -$4000.0 recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Exchange Rate Effect high stood at $1.4 million for Q4 2023, and its period low was -$2.1 million during Q4 2024.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$72000.0 (2023), whereas its average is -$76200.0.
  • Within the past 5 years, the most significant YoY rise in Prestige Consumer Healthcare's Exchange Rate Effect was 57357.14% (2024), while the steepest drop was 2006666.67% (2024).
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Exchange Rate Effect stood at -$230000.0 in 2021, then skyrocketed by 446.96% to $798000.0 in 2022, then skyrocketed by 77.32% to $1.4 million in 2023, then plummeted by 246.71% to -$2.1 million in 2024, then surged by 113.1% to $272000.0 in 2025.
  • Its Exchange Rate Effect was $272000.0 in Q4 2025, compared to -$4000.0 in Q3 2025 and $825000.0 in Q2 2025.